Month: October 2020

Japan has become one of the top 10 most popular destinations for U.S. students studying abroad. According to the President of the Institute of International Education, Dr. Allen E. Goodman, “International experience is one of the most important components of a 21st-century education, and study abroad should be viewed as an essential element of a college degree.”
0 Comments
Tracey Ryniec and Kevin Cook take a look at two highly ranked stocks.’ Alteryx: https://www.zacks.com/stock/quote/AYX?cid=CS-YOUTUBE-FT-VID InMode: https://www.zacks.com/stock/quote/INMD?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: http://stocktwits.com/ZacksResearch Follow us on Twitter: https://twitter.com/ZacksResearch Like us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
0 Comments
In 2020, many drug stocks have behaved like pot stocks did in 2018. Investors have paid huge premiums on sales for even the promise of a novel coronavirus treatment or vaccine. But if you’re looking for value, consider Pfizer (NYSE:PFE). You can still buy PFE stock at a reasonable price. Source: Manuel Esteban / Shutterstock.com
0 Comments
For investors, there’s playing the lottery. And then there’s Sorrento Therapeutics (NASDAQ:SRNE). The unassuming biotech firm initially made headlines in May when it suggested it had a “cure” for coronavirus. SRNE stock initially spiked 140% before investors saw through the misstatement. Source: Shutterstock The company then saw its second wave of interest in August after
0 Comments
With the Las Vegas Strip continuing to rebound and MGM (NYSE:MGM) receiving a roughly $1 billion investment from IAC (NASDAQ:IAC), the outlook of MGM stock has improved. Source: Michael Neil Thomas / Shutterstock.com Additionally, following the widespread introduction of a successful vaccine for the novel coronavirus, MGM is set benefit from a huge amount of
0 Comments
CNBC’s Jim Cramer said Friday the gains on Wall Street since March’s coronavirus lows fail to reflect the economic struggles throughout the U.S. and the need for additional stimulus.  “The people need this. The stock market doesn’t show it, but the people absolutely need it.,” Cramer said on “Squawk on the Street.”  The status of
0 Comments
Some are calling it “a la carte stimulus,” with aid for airlines in column A, PPP aid in Column B, etc.  Whatever it is,  hopes for stimulus — pre-election, post-election, comprehensive package, stand-alone deal, whatever and whenever — is supporting breakouts in cyclicals like industrials, materials, consumer discretionary, and banks. Many big names like Caterpillar,
0 Comments
Never underestimate a good dividend. For that matter, never underestimate a quality company, brand and stock either. McDonald’s (NYSE:MCD) fits all of these criteria. That’s why it’s no surprise that McDonald’s stock is hitting new all-time highs. Source: ATIKAN PORNCHAIPRASIT / Shutterstock.com Even better, though, is that the thesis behind owning the stock doesn’t depend
0 Comments
Jen-Hsun Huang, president and chief executive officer of Nvidia Corp., speaks during the company’s event at Mobile World Congress Americas in Los Angeles on Oct. 21, 2019. Patrick T. Fallon | Bloomberg | Getty Images Check out the companies making headlines after the bell Thursday: GenMark Diagnostics — GenMark shares popped more than 4% after
0 Comments
Bonds are often considered to be plain and boring when compared to equities. This may be the case, but bonds can provide a level of stability that equities, due to their volatility, generally can’t match. This is especially true of bond funds, which can provide a safe and stable source of income as well as
0 Comments
BP Plc (NYSE:BP) has had a rough year. In 2020,  BP stock is down over 54%. Nevertheless, the stock is likely worth at least 20% more than its present price of $17.27, based on its historical dividend yield. Source: FotograFFF / Shutterstock.com Due to the Covid-19 pandemic, oil and gas prices have tumbled amid reduced
0 Comments
CNBC’s Jim Cramer on Thursday advised investors to not buy shares of Regeneron Pharmaceuticals, simply because President Donald Trump touted the company’s potential coronavirus treatment.  Regeneron’s stock was higher by 2% on Thursday. In a video posted Wednesday, Trump claimed that Regeneron’s experimental antibody treatment for Covid-19, which the president received for his illness, was “a cure.” 
0 Comments